Khan Najat 4

What Happened
Najat Khan, CEO, President and a director of Recursion Pharmaceuticals (RXRX), had 14,280 shares withheld by the company to satisfy tax withholding obligations related to the net settlement of restricted stock units. The filing shows the shares were disposed at $3.49 per share for a total of $49,837.

Key Details

• Transaction date: 2026-02-17; Filing date: 2026-02-19 (filed timely).
• Shares withheld/disposed: 14,280 at $3.49 per share; total value reported $49,837.
• Transaction code: F — shares withheld to satisfy tax withholding on net-settled RSUs. (Footnote: shares withheld by the issuer to satisfy its tax withholding and remittance obligations.)
• Shares owned after transaction: Not specified in the provided filing details.

Context
This was not an open-market sale or purchase by the insider but a routine withholding of shares to cover taxes from an RSU settlement (a net settlement/cashless-type mechanism). Such withholdings are common and generally reflect tax logistics rather than a signal about the insider’s view of the stock.